Thomas Breuer and colleagues at GlaxoSmithKline respond to Peter Doshi
BMJ
.
2018 Oct 3:363:k4116.
doi: 10.1136/bmj.k4116.
Authors
Thomas Breuer
1
,
Vincent Bauchau
1
,
Tatjana Poplazarova
1
,
Jens-Ulrich Stegmann
1
Affiliation
1
GSK Vaccines, 20 Avenue Fleming, 1300 Wavre, Belgium.
PMID:
30282702
DOI:
10.1136/bmj.k4116
No abstract available
Publication types
Letter
MeSH terms
Humans
Influenza Vaccines*
Influenza, Human / prevention & control
Information Dissemination
Patient Safety
Substances
Influenza Vaccines
pandemrix